A Clinical Study to Evaluate the Efficacy of Paste in the Management of Acne Vulgaris

A Clinical Study To Evaluate The Efficacy Of Zimad (Arad karasna with Shahad) In The Management Of Basoor-e-Labaniya (Acne Vulgaris) - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/08/071810

Enrollment

Registered

2024-08-02

Start date

Unknown

Completion date

Unknown

Last updated

2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L700- Acne vulgaris

Interventions

Intervention1: Zimad (Aradkarasna with shahad): Enrolled cases of basoor-e-labaniya (acne vulgaris), after obtaining a written informed consent will be allocated with 44 patients. Site: Face, upper b

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients of both genders. 2. Patients who are between 15 years to 30 years. 3. Patients willing to follow protocol.

Exclusion criteria

Exclusion criteria: 1. Patients who are under 15 years and above 30 years. 2. Known case of Diabetes Mellitus. 3. Patients on corticosteroid therapy, anti-convulsant therapy. 4. Known case of any systemic disease or concomitant disorders like acne rosacea, acne fulminans, acne necrotica, psoriasis, eczema etc. 5. Patient who do not agree to follow the study protocol. 6. Allergic patient.

Design outcomes

Primary

Measure	Time frame
1.Severity of acne 2.Cook’s grading scale. Timepoint: 0,7,14,21,28,35 days	—

Secondary

Measure	Time frame
1. Cook’s grading scale. 2. Dermatology life quality index (DLQI). 3. Improve quality of life.Timepoint: 0,35 Days.	—

Countries

India

Contacts

Public ContactAriba Javed

state unani medical college, prayagraj

nusratparveen12755@gmail.com7906813040

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026